141 related articles for article (PubMed ID: 32612672)
1. Cryptotanshinone attenuates the stemness of non-small cell lung cancer cells via promoting TAZ translocation from nuclear to cytoplasm.
Jin L; Wu Z; Wang Y; Zhao X
Chin Med; 2020; 15():66. PubMed ID: 32612672
[TBL] [Abstract][Full Text] [Related]
2. Curcumin suppresses the stemness of non-small cell lung cancer cells via promoting the nuclear-cytoplasm translocation of TAZ.
Zheng Y; Yang X; Tan J; Tian R; Shen P; Cai W; Liao H
Environ Toxicol; 2021 Jun; 36(6):1135-1142. PubMed ID: 33539684
[TBL] [Abstract][Full Text] [Related]
3. SHP2 inhibitor specifically suppresses the stemness of KRAS-mutant non-small cell lung cancer cells.
Jiang L; Xu W; Chen Y; Zhang Y
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3231-3238. PubMed ID: 31373232
[TBL] [Abstract][Full Text] [Related]
4. FOXC1 induces cancer stem cell-like properties through upregulation of beta-catenin in NSCLC.
Cao S; Wang Z; Gao X; He W; Cai Y; Chen H; Xu R
J Exp Clin Cancer Res; 2018 Sep; 37(1):220. PubMed ID: 30189871
[TBL] [Abstract][Full Text] [Related]
5. CircRNA CDR1as/miR-641/HOXA9 pathway regulated stemness contributes to cisplatin resistance in non-small cell lung cancer (NSCLC).
Zhao Y; Zheng R; Chen J; Ning D
Cancer Cell Int; 2020; 20():289. PubMed ID: 32655321
[TBL] [Abstract][Full Text] [Related]
6. RNA Demethylase ALKBH5 Prevents Lung Cancer Progression by Regulating EMT and Stemness
Liu X; Wang Z; Yang Q; Hu X; Fu Q; Zhang X; Li W
Front Oncol; 2022; 12():858694. PubMed ID: 35530319
[TBL] [Abstract][Full Text] [Related]
7. Dichloroacetate attenuates the stemness of hepatocellular carcinoma cells via promoting nucleus-cytoplasm translocation of YAP.
Su D; Lin Z
Environ Toxicol; 2021 May; 36(5):975-983. PubMed ID: 33405312
[TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA MACC1-AS1 promotes the stemness of nonsmall cell lung cancer cells through promoting UPF1-mediated destabilization of LATS1/2.
Wang X; Yu X; Wei W; Liu Y
Environ Toxicol; 2020 Sep; 35(9):998-1006. PubMed ID: 32401390
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA FENDRR attenuates the stemness of non-small cell lung cancer cells via decreasing multidrug resistance gene 1 (MDR1) expression through competitively binding with RNA binding protein HuR.
Gong F; Dong D; Zhang T; Xu W
Eur J Pharmacol; 2019 Jun; 853():345-352. PubMed ID: 30981768
[TBL] [Abstract][Full Text] [Related]
10. Phosphodiesterase 5/protein kinase G signal governs stemness of prostate cancer stem cells through Hippo pathway.
Liu N; Mei L; Fan X; Tang C; Ji X; Hu X; Shi W; Qian Y; Hussain M; Wu J; Wang C; Lin S; Wu X
Cancer Lett; 2016 Aug; 378(1):38-50. PubMed ID: 27179930
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-103a Curtails the Stemness of Non-Small Cell Lung Cancer Cells by Binding OTUB1 via the Hippo Signaling Pathway.
Hu Z; Xiao D; Qiu T; Li J; Liu Z
Technol Cancer Res Treat; 2020; 19():1533033820971643. PubMed ID: 33174524
[TBL] [Abstract][Full Text] [Related]
12. LncRNA ASAP1-IT1 enhances cancer cell stemness via regulating miR-509-3p/YAP1 axis in NSCLC.
Liu Y; Yang Y; Zhang L; Lin J; Li B; Yang M; Li H; Chen K; Zhao W
Cancer Cell Int; 2021 Oct; 21(1):572. PubMed ID: 34715859
[TBL] [Abstract][Full Text] [Related]
13. Glutathione metabolism is essential for self-renewal and chemoresistance of pancreatic cancer stem cells.
Jagust P; Alcalá S; Sainz Jr B; Heeschen C; Sancho P
World J Stem Cells; 2020 Nov; 12(11):1410-1428. PubMed ID: 33312407
[TBL] [Abstract][Full Text] [Related]
14. Zoledronic acid inhibits the growth of cancer stem cell derived from cervical cancer cell by attenuating their stemness phenotype and inducing apoptosis and cell cycle arrest through the Erk1/2 and Akt pathways.
Wang L; Liu Y; Zhou Y; Wang J; Tu L; Sun Z; Wang X; Luo F
J Exp Clin Cancer Res; 2019 Feb; 38(1):93. PubMed ID: 30791957
[TBL] [Abstract][Full Text] [Related]
15. YB-1 interplays with ERα to regulate the stemness and differentiation of ER-positive breast cancer stem cells.
Yang F; Chen S; He S; Huo Q; Hu Y; Xie N
Theranostics; 2020; 10(8):3816-3832. PubMed ID: 32206124
[No Abstract] [Full Text] [Related]
16. Astragaloside IV enhances the sensitivity of breast cancer stem cells to paclitaxel by inhibiting stemness.
Huang P; Li H; Ren L; Xie H; Chen L; Liang Y; Hu Y; Selistre-de-Araujo HS; Boussios S; Jhawar SR; Cui R; Zuo Q; Chen Q
Transl Cancer Res; 2023 Dec; 12(12):3703-3717. PubMed ID: 38193000
[TBL] [Abstract][Full Text] [Related]
17. Histone demethylase KDM6A coordinating with KMT2B regulates self-renewal and chemoresistance of non-small cell lung cancer stem cells.
Chen Z; Qi Y; Shen J; Chen Z
Transl Oncol; 2023 Nov; 37():101778. PubMed ID: 37683307
[TBL] [Abstract][Full Text] [Related]
18. Cryptotanshinone targets tumor-initiating cells through down-regulation of stemness genes expression.
Zhang Y; Cabarcas SM; Zheng JI; Sun L; Mathews LA; Zhang X; Lin H; Farrar WL
Oncol Lett; 2016 Jun; 11(6):3803-3812. PubMed ID: 27313698
[TBL] [Abstract][Full Text] [Related]
19. PRRX1 isoform PRRX1A regulates the stemness phenotype and epithelial-mesenchymal transition (EMT) of cancer stem-like cells (CSCs) derived from non-small cell lung cancer (NSCLC).
Sun L; Han T; Zhang X; Liu X; Li P; Shao M; Dong S; Li W
Transl Lung Cancer Res; 2020 Jun; 9(3):731-744. PubMed ID: 32676335
[TBL] [Abstract][Full Text] [Related]
20. Limonin attenuates the stemness of cervical carcinoma cells by promoting YAP nuclear-cytoplasmic translocation.
Zhao W; Wu M; Cui L; Du W
Food Chem Toxicol; 2019 Mar; 125():621-628. PubMed ID: 30738134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
